Antibodies | Vasculitis Clinical Research Consortium

Skip to main content

Search

Join Our Contact Registry

RDCRN Alumni badge

Header Social Media

Main navigation

Our Research
Patients and Families
Researchers and Clinicians
Early Stage Investigators
News and Events
- Latest News
About Us

A Previously-Funded NIH Rare Diseases Clinical Research Network Consortium

Special protein substances made by the body’s white blood cells for defense against bacteria and other foreign substances.

Footer menu

Web Policies
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Vasculitis Clinical Research Consortium (VCRC) is a previously funded research group of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). VCRC received funding under grant number U54AR057319 as a collaboration between NCATS and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818. The content of this website is solely the responsibility of the VCRC administrative coordinating center at University of Pennsylvania and does not necessarily represent the official views of the NIH.